Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double-blind comparison with crossover treatment of nonresponders-Reference-Cited by-同舟云学术

Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double-blind comparison with crossover treatment of nonresponders

Published:2000-06 Issue:6 Volume:22 Page:760-769
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Prenner Bruce M.,Capano David,Harris Alan G.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference11 articles.

1. Prevalence of allergic rhinitis in the United States;Nathan;J Allergy Clin Immunol,1997

2. Symptom control in patients with hay fever in UK general practice: How well are we doing and is there a need for allergen immunotherapy?;White;Clin Exp Allergy,1998

3. Seasonal allergic rhinitis—a review of current therapy;Lund;Allergy,1996

4. Treating allergic rhinitis with second-generation antihistamines;Nightingale;Pharmacotherapy,1996

5. The economic impact of allergic rhinitis;Storms;J Allergy Clin Immunol,1997

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the role of loratadine in optimally managing and in alleviating the burden of allergic rhinitis;IP Journal of Otorhinolaryngology and Allied Science;2023-01-15

2. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials;BMC Pharmacology and Toxicology;2019-11-29

3. Clinical Practice Guideline;Otolaryngology–Head and Neck Surgery;2015-02

4. Solutions as solutions – Synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals;European Journal of Pharmaceutics and Biopharmaceutics;2011-11

5. Effects of Curcumin on the Pharmacokinetics of Loratadine in Rats: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Curcumin;Biomolecules and Therapeutics;2011-07-31